Member Info for Adamski1.

part 2 .....

Again, this is far from unique to 4D, or even the pharmaceutical sector. When guidance is required to be updated, we seek to do so in a timely manner that is fair and accessible to all shareholders. The LSE does not generally look kindly on commentary by Directors on share price movements, regardless of our own views as discussed above, as they tend to view this as manipulation. Similarly, communicating specific commentary or material updates ahead of public announcements with individual investors is also viewed as providing an unfair advantage.

As you know, 4D pharma senior management have also invested significant personal capital in the company over successive funding rounds. We absolutely feel your frustration, and remain confident that our approach, our science, and our pipeline will ultimately bear fruit and deliver the value it deserves to our shareholders and to patients.

Regards

Duncan Peyton
CEO
4D pharma

Investor Relations, 4D pharma plc



4D pharma plc
Fifth Floor
9 Bond Court
Leeds
LS1 2JZ
United Kingdom

ir@4dpharmaplc.com

Didn't take long to gain a response. At least investor relations is good......part 1 as i cannot fit it all onto one message -

Dear Adam

Let me start by saying we share your frustration regarding the share price performance over the last year. Whilst this may not address your immediate concern, we assure you that this is a trend being seen across the sector, and it is not just us at 4D pharma that has found the market’s reaction to positive data hard to understand, so do banks, analysts and other stakeholders that we speak to.

We hope you can appreciate that we cannot comment on the investment strategy of any one investor but, as we are all aware, US biotech investors have been hit hard this year and the steady decline of the Nasdaq Biotechnology Index since August this year demonstrates this. The last few months have seen this pressure only increase, however how this pattern continues or corrects itself will become evident in the New Year. This isn’t just our view - it is the view reflected by brokers, banks, PR and IR firms across the sector on both sides of the Atlantic.

From a perspective of the microbiome field and our other listed peers, the situation through 2021 has been similar. We have seen companies such as Seres and Forte Biosciences have significant setbacks in their portfolio leading to significant share price drops (circa 65% and 90% YTD, respectively). This has led to broader investor uncertainty regarding the microbiome, irrespective of genuine read-through in terms of science, approach and disease areas. Like 4D, other companies which have announced positive and material progress in their pipelines this year have also seen their share price decline despite good news (e.g. approximately EVLO -30%, SYBX -50%, FNCH -55%, KLDO -70%, PHGE -77%).

In terms of selling and trading of 4D pharma stock specifically, we continue to see high volumes of small trades which seem to reflect UK retail trading in and out of small share price movements, which makes consistent momentum hard to attain. It is of course the right of these traders, as with any shareholder, to buy and sell as they see fit, irrespective of the impact on the business.

The above factors are unfortunately clearly having an adverse effect on the impact of any news we release. We see congratulations upon the delivery of news which is objectively material progress, before the above external market factors impact the share price. In our view, the way to overcome this is to continue to do what we do best – develop new drugs and generate more positive clinical data. We made significant progress across our strong pipeline in 2021, de-risked across multiple candidates in different diseases, and we expect to continue in 2022 and beyond.

We of course update the market as and when we have material updates in a timely manner. Unfortunately, over the last two years the ever-present disruption of COVID-19 has at times impacted our timelines.

Sent: 30 December 2021 22:04
To: ir@4dpharmaplc.com; info@4dpharmaplc.com
Subject: URGENT Investor question...

Dear Sir/Madam.

I have invested a large sum of my hard earnt money into 4D pharma as I believe in the business.

I do have some serious reservations concerning the constant depreciation of share price over the past couple of months, even with milestones in business being successfully met.

I believe this is due to major share holder Steven Oliveira constantly selling, proved though - holding in company RNS, issued by yourselves.

As per the latest holdings in company RNS dated 7th December 2021, Steven Oliveira has 7.69% holding in company. If he was to completely sell down all shares, looks like he is doing so, this will take months to offload all shares and any piece of good news/milestones met will be sold into, therefore depreciating the share price along with other share holders/institutional investors motivation and enthusiasm for the business, resulting in loosing faith and selling even more shares in the business.

May I ask, what the company is doing to rectify this situation? Is the company in a position to negotiate with Steven Oliveira to sell his shares to other long-term investors, who believe in the business?

Having spoken to a lot of other long term investors, we are all deeply concerned and feeling worried about our investment here and want to prevent a “ blood bath” of further selling occurring.

Really appreciate your earliest response.

Kind regards

....lets see what response i get, if any?!

so how do we know the 2 for 1 shares represents value? The new shares could be 50 cents each?! Am i missing something?

Does anyone know what the value of new tils shares will be on nasdaq? thanks

https://www.shortdata.co.uk/company.php?isin=GB00BJL5BR07

Been waiting for the license to be granted for years...now its here.

Have used all spare cash to buy, this should spike highly today!!

Good luck all

Good to have some perspective on the matter Riz.

People are naturally annoyed about the price drop, me included. We know this is due to a former legacy holder who is selling all.

We know when he is done, might be now as I haven't seen any late sells, the share price will spring back into life.

Furthermore, we still await news on aptamer for covid-19, this will rocket the share price, like NCYT,ODX etc.
I like the fact, from the studies aptamers have been much more better than the antibody tests, which have a poor accuracy rate, so there is still much room in the market for this and not just this country but around the whole world!!

Until then, shares are the transfer from the impatient to the patient and the MM are in control playing their games...seen this happen many times before. VRS is a great example, same happened there, sold a couple of months later for 1100%....it can happen!

Chill out, enjoy the weather, go for a long walk and relax.

….if you believe that code, that means an rns is logged but is it bad news as sell or doesn't it matter?

or was it actually a buy?

This share is complete dog poo!
I sold out at 21p with 45% loss...best thing i did otherwise would be looking at a massive loss now.
It doesn't matter if Vince has heavily invested, it just means he is heavily underwater now.
DYOR...but its only going 1 way....down the pan!!!

Good luck all

last week, even with good news this share falls.

Good luck....i think you are going to need it!!

once again decent news has been released and this share does nothing!! Something is clearly wrong here!

It must be to certain rampers here have looked vince, in the eyes and know this investment is brilliant due to that, bunch of idiots!! They are looking into mistike megs eyes and have fallen in love!! more like septic peg...lol

Looking brilliant here guys, well done on a cracking investment!

...what a great investment this is!!!

....people have been selling. Something wrong with this share and some of the pump artists that just post figures about how good the assets are! Well....no many people agree with you hence why they are selling.

Don't get married to this share, you will just lose all profits. Look at some of the muppets that post all field results all the time of twitter, they try to appear to be intelligent when in reality they are self righteous losers!!

i have sold 10% of my holding here yesterday so that I can have funds to acquire a new car.
I haven't sold anything today, so its not me.....try some other conspiracy theory??!! lol

I think the 1.5 million sell we had a few weeks back and director selling is aiding to this drop. We have lost our advantage of having low freefloat now, there are many shares available to buy. I found it very difficult yesterday to sell, but easy to buy, the MM don't want our shares? PI are just loosing confidence.

I noticed that the RSI is the most oversold since june 2016, is this the bottom or more to go?

Completely agree Mike, there is something really strange here and I don't like it. I sold a small portion of my holding here as my confidence is eroding away! May well cut more over the following period.
Every time we get good news it just drops so seems pointless holding for the amazing news as we would just have an amazing drop!

Very disappointed!

wow....come on irr, keep on going! Even with all my other stocks in my portfolio are down today, with my larger position in irr, I am actually in profit in my whole portfolio today. Goes to show, you should always have a diverse portfolio for times like this!

on my watchlist apart from irr, this makes refreshing change.

Looks much better today with a few more buys, hope this is the start of a long overdue re-rate.